About Lumeda
Lumeda is a company based in Rocky Hill (United States) founded in 2020 by Paul E Sanders and Trevor MacDougall. Lumeda has raised $5.34 million across 2 funding rounds from investors including Connecticut Innovations and Cycle Capital. The company has 10 employees as of December 31, 2022. Lumeda offers products and services including DigiLum™. Lumeda operates in a competitive market with competitors including Pulmonx, PhotoPharmics, Neurent Medical, Gradient Denervation Technologies and Spiration, among others.
- Headquarter Rocky Hill, United States
- Employees 10 as on 31 Dec, 2022
- Founders Paul E Sanders, Trevor MacDougall
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lumeda Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.34 M (USD)
in 2 rounds
-
Latest Funding Round
$4.3 M (USD), Series A
Feb 01, 2021
-
Investors
Connecticut Innovations
& 1 more
-
Employee Count
10
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lumeda
Lumeda offers a comprehensive portfolio of products and services, including DigiLum™.
System for precise light dosing in treating solid tumors like lung cancer.
People of Lumeda
Unlock access to complete
Unlock access to complete
Scientific Team
5 people
Senior Team
2 people
Founder Team
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of Lumeda
Lumeda has successfully raised a total of $5.34M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.3 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lumeda
Lumeda has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Connecticut Innovations and Cycle Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Locked | Locked | Locked | |
|
Cycle Capital is engaged in venture capital for clean tech innovations.
|
Locked | Locked | Locked |
Investor details for Lumeda
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lumeda
Investment portfolio details for Lumeda
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lumeda
Detailed financials for Lumeda
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lumeda Comparisons
Peer comparison for Lumeda
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lumeda
Lumeda operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pulmonx, PhotoPharmics, Neurent Medical, Gradient Denervation Technologies and Spiration, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of smart devices for treating pulmonary diseases
|
|
| Locked | Locked | Locked |
Non-invasive phototherapy for Parkinson's disease is developed.
|
|
| Locked | Locked | Locked |
Smart devices for minimally invasive rhinitis treatment are developed.
|
|
| Locked | Locked | Locked |
Endovascular catheter-based technology for pulmonary hypertension treatment is provided.
|
|
| Locked | Locked | Locked |
IntraBronchial Valve to treat lung disease
|
|
| Locked | Locked | Locked |
Minimally invasive devices for brain tumor treatment are provided.
|
Detailed competitors of Lumeda
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lumeda
Complete news archive for Lumeda
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lumeda
Lumeda was founded in 2020.
Lumeda is headquartered in Rocky Hill, United States. It is registered at Rocky Hill, Connecticut, United States.
Alexander Zinke is the current CEO of Lumeda.
Lumeda is a funded company, having raised a total of $5.34M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Lumeda is 10.
Lumeda was founded in 2020 and is based in Rocky Hill, United States. A photodynamic therapy device is developed by the company for lung cancer treatment within the medical device sector. Optical technology is utilized, along with photonics instrumentation and proprietary software, to automate light delivery to tumors and manage dosimetry profiles. Operations focus on advancing targeted oncology solutions through automated PDT applications.
Lumeda's top competitors include Pulmonx, PhotoPharmics and Neurent Medical.
Lumeda offers DigiLum™.
Lumeda has 2 investors. Key investors include Connecticut Innovations, and Cycle Capital.